E
EXAS

Ergoteles’s Exact Sciences EXAS Stock Holding History

Ergoteles’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,081
Closed -$3.01M – 313
2023
Q2 		$3.01M Buy
32,081
+28,159
+718% +$2.2M 0.14% 178
2023
Q1 		$266K Sell
3,922
-14,834
-79% -$953K 0.01% 927
2022
Q4 		$929K Buy
+18,756
New +$766K 0.03% 484
2022
Q2 		– Sell
-105,759
Closed -$7.39M – 1745
2022
Q1 		$7.39M Buy
+105,759
New +$7.73M 0.28% 85
2021
Q4 		– Sell
-8,507
Closed -$812K – 1337
2021
Q3 		$812K Buy
+8,507
New +$898K 0.03% 435
2021
Q2 		– Sell
-59,782
Closed -$7.88M – 1548
2021
Q1 		$7.88M Buy
+59,782
New +$8.18M 0.25% 105

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ergoteles's EXAS Position: Q3 2023 in Review

Ergoteles sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 32,081 shares — an estimated $3.01M sold.

Ergoteles first reported a position in EXAS in Q1 2021 and held it in 6 quarters. The position peaked at $7.88M in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Ergoteles reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 32,081 Exact Sciences shares in Q3 2023, an estimated $3.01M.
  • Ergoteles first reported a position in Exact Sciences in Q1 2021 and held it in 6 quarters.
  • Ergoteles's Exact Sciences position peaked at $7.88M in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.